Covered recipient · General Payments record
AMULYA V PENMETSA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2025
$321.35
- Reported across 8 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.35 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Madrigal Pharmaceuticals | $145.45 | 1 |
| ABBVIE INC. | $65.59 | 2 |
| Janssen Biotech, Inc. | $49.35 | 3 |
| Gilead Sciences, Inc. | $47.09 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $321.35 | 8 |
Payment records · PY2025 (8)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $43.02 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203569115 | CMS |
| ABBVIE INC. | $22.57 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203569123 | CMS |
| Gilead Sciences, Inc. | $47.09 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234414792 | CMS |
| Janssen Biotech, Inc. | $16.66 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175450922 | CMS |
| Janssen Biotech, Inc. | $18.56 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174257615 | CMS |
| Janssen Biotech, Inc. | $14.13 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175450192 | CMS |
| Madrigal Pharmaceuticals | $145.45 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248298504 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.87 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223812374 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.